Giant cell arteritis (GCA) without concurrent polymyalgia rheumatica — a granulomatous large-vessel vasculitis affecting the aorta and its branches, most commonly the temporal and cranial arteries, in patients typically aged 50 or older.
Verified May 8, 2026 · 6 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 5
- Region
- Other
Documentation tips
What should appear in the chart to support M31.6.
Source · Editorial brief grounded in 6 cited references ↓
- Document explicitly that polymyalgia rheumatica is absent or not diagnosed — this single distinction drives the M31.6 vs. M31.5 choice and prevents payer downcoding.
- Record the patient's age in the note; GCA coding carries implicit clinical validation expectations for age ≥50, and absence of this detail invites audit scrutiny.
- Capture inflammatory marker results (ESR and CRP values with units) and temporal artery biopsy or duplex ultrasound findings to substantiate medical necessity for vascular studies.
- If GCA-associated myopathy is also documented, code G72.9 (or the more specific myopathy code) as an additional diagnosis — the ICD-10-CM index cross-references M31.6 to myopathy in giant cell arteritis.
- Note the presenting cranial symptoms (headache, jaw claudication, visual changes, scalp tenderness) by name rather than as generic 'vascular symptoms' to support specificity.
Related CPT procedures
Procedure codes commonly billed with M31.6. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M31.6 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Assigning M31.5 when PMR is not explicitly documented — shoulder or hip girdle pain alone does not constitute PMR; provider documentation of both diagnoses is required before using M31.5.
- Using I77.6 (Arteritis, unspecified) when the record clearly states giant cell arteritis or temporal arteritis — both index to M31.6, making I77.6 a less specific and potentially denying code.
- Omitting M31.6 as a secondary diagnosis when GCA-related myopathy is the primary complaint presented in an orthopedic setting — the index explicitly maps myopathy in GCA to M31.6.
- Confusing M31.4 (Aortic arch syndrome/Takayasu) with M31.6 when large-vessel GCA involves the aorta — Takayasu arteritis is a distinct entity with its own code; GCA of the aorta in patients ≥50 maps to M31.6.
Clinical context
Source · Editorial summary grounded in 6 cited references ↓
M31.6 is the correct code for giant cell arteritis when polymyalgia rheumatica (PMR) is NOT documented concurrently. It covers temporal arteritis, cranial arteritis, and giant cell NEC — all indexed to this code. The critical decision point is whether PMR coexists: if the record documents both GCA and PMR, use M31.5 instead. M31.6 and M31.5 are mutually exclusive; M31.5 has an Excludes1 relationship with GCA-without-PMR.
Although M31.6 sits in Chapter 13 (Diseases of the Musculoskeletal System and Connective Tissue) under the necrotizing vasculopathies block (M30–M36), it surfaces frequently in orthopedic and rheumatology practices when shoulder girdle or hip girdle pain prompts a PMR workup and GCA is identified without PMR features. Orthopedic coders encounter this code as a secondary diagnosis when GCA-related myopathy is documented alongside a musculoskeletal complaint.
Clinical validation for M31.6 requires documented support: age ≥50, cranial symptoms (headache, jaw claudication, scalp tenderness, visual disturbance), elevated inflammatory markers (ESR ≥50 mm/hr or CRP ≥10 mg/dL), and ideally positive temporal artery biopsy or vascular imaging findings. When the record supports GCA but PMR status is undocumented, query the provider before assigning M31.5 — do not infer PMR from shoulder or hip pain alone.
Sibling codes
Other billable codes under M31 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01What is the difference between M31.5 and M31.6?
02Is temporal arteritis coded to M31.6?
03Does M31.6 require a 7th character?
04Can M31.6 appear as a secondary diagnosis in an orthopedic encounter?
05What CPT codes for vascular studies are commonly paired with M31.6?
06Does M31.6 have any Excludes notes that affect coding?
07What documentation supports medical necessity when billing vascular studies for M31.6?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M30-M36/M31-/M31.6
- 03icdcodes.aihttps://icdcodes.ai/diagnosis/giant-cell-arteritis/documentation
- 04icdcodes.aihttps://icdcodes.ai/icd10/M31.6
- 05aapc.comhttps://www.aapc.com/codes/icd-10-codes/M31.6
- 06cms.govhttps://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=56758&ver=61
Mira AI Scribe
Mira AI Scribe captures the provider's explicit statement that GCA is present without polymyalgia rheumatica, along with patient age, cranial symptom details (headache, jaw claudication, visual changes), ESR/CRP values, and biopsy or imaging results. This prevents defaulting to the less specific I77.6 or the incorrect M31.5 when PMR is absent from the record.
See how Mira captures M31.6 documentation